Latest News

COMMUNIQUE: RIFAPENTINE GLOBAL PRICE DISCOUNT

Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria, Sanofi SA, and the Stop TB Partnership is pleased to announce a significant reduction in the price of rifapentine (Priftin®) manufactured by Sanofi SA. Read more here
Read More

Breaking News: Pricing Agreement Makes TB Prevention Affordable for High-Burden, Low, Lower-Middle and Upper-Middle Income Countries

Press Release Pricing Agreement Makes TB Prevention Affordable for High-Burden, Low-, Lower-Middle and Upper-Middle Income Countries Aurum Institute on behalf of the IMPAACT4TB project congratulates Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria and Sanofi for having reached a volume-based agreement, securing a significant price discount for rifapentine (Priftin®) Hyderabad (31 October 2019)—A...
Read More

IMPAACT4TB Satellite Session, 1 Nov 2019 @ the Union Conference

The IMPAACT4TB Consortium will be hosting a Satellite Session at the Union Conference as an introduction to a Short Course Prevention Therapy, 3HP. Looking forward to seeing you there!  
Read More

WHO Global TB report 2019

The latest WHO Global TB report  2019 was published on 20 October 2019 and has been every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in the prevention, diagnosis and treatment of the disease, at global, regional and country...
Read More

Pediatric TB Diagnosis, Prevention, and Treatment of TAG 2019 Pipeline Report

TAG, our Consortium Partner has launched the Pediatric Tuberculosis (TB) section of their  2019 Pipeline Report. This section provides an overview of the research and development of innovations for diagnosing, preventing, treating TB in children. You can now read online and download  Paediatric TB Diagnosis, Prevention, and Treatment by Lindsay McKenna
Read More

Our latest IMPAACT4TB newsletter is out!

No #EndAIDS without #EndTB From 20-24 July 2019, members of the IMPAACT4TB Consortium were in Mexico City, where they joined hundreds of other delegates in discussing the links between HIV and TB, and the implications of TB prevention for people living with HIV.
Read More